companiesandmarkets.com

Return to Report | Print

Optimer Pharmaceuticals Inc - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/optimer-pharmaceuticals-inc-premium-company-profile-41200.asp

Report Summary

Introduction

Optimer is a biopharmaceutical company focused on the discovery, development and global commercialization of anti-infective products for the treatment of serious infectious diseases. The Company currently has two late stage anti-infective product candidates, OPT-80 (Difimicin) and Prulifloxacin, at Phase III trials.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    Optimer in-licensed Difimicin from Par Pharmaceuticals and Prulifloxacin from Nippon Shinyaku. In addition, the company has acquired OPopS technology from The Scripps Research Institute. Utilizing the OPopS technology the company is developing Difimicin and other internal products.

    Optimer recognized its historical revenues from 2004. During 2004-2006, total revenue growth was nearly constant derived from sole revenue stream, license fees, collaboration and others. The significant decline in revenues from $2 in 2005 to $1 million in 2006 was due to the lowered Small Business Innovation Research Program (SBIR) grants.

    Optimer’s total revenues during 2006-2010 are forecasted with an absolute growth of +$97 million with sales increasing from $1 million to $98 million grows at a CAGR of 21%. The increase was primarily due to the forecasted revenues from Difimicin and Prulifloxacin.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company’s adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 8
    Company Financials 9
    P&L 9
    Balance Sheet 12
    Cash Flow 12
    Products & Services 13
    Pipeline Products 13
    AC Forecast Product Sales 15
    Competitors and Strategic Business Relationships 17
    Key Competitors 17
    Key Suppliers 18
    Key Clients 18
    Shareholding Structure 19
    Strategy 20
    Company View 20
    Corporate Strategy 22
    SWOT Analysis 23
    Overview 23
    Strengths 24
    Weaknesses 25
    Opportunities 26
    Threats 27
    Value Chain Analysis 28
    Overview 28
    Product Discovery and Development 28
    Scorecard 29
    Overview 29
    Scorecard Analysis 30
    Key Employees 31
    List of Key Employees 31
    Key Employee Biographies 32
    Financial and Operational Overview 38
    Financial and Operational Overview 38
    Appendix 40
    Ask the analyst 40
    Datamonitor consulting 40
    Disclaimer 40


    TABLE OF FIGURES
    Figure 1: Optimer Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 10
    Figure 2: Optimer Pharmaceuticals- Key Strategic Revenues, 2006-2010 ($ Mn) 16


    TABLES
    Table 1: Optimer Pharmaceuticals- Key Facts 6
    Table 2: Optimer Pharmaceuticals- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 9
    Table 3: Optimer Pharmaceuticals- Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 11
    Table 4: Optimer Pharmaceuticals- Balance Sheet 12
    Table 5: Optimer Pharmaceuticals- Cash Flow 12
    Table 6: Optimer Pharmaceuticals - In-house Pipeline Products 13
    Table 7: Optimer Pharmaceuticals- Collaboration Products 14
    Table 8: Optimer Pharmaceuticals- Forecast Sales, 2006-2010 ($ Mn) 15
    Table 9: Optimer Pharmaceuticals - Key Competitors 17
    Table 10: Optimer Pharmaceuticals- Key Suppliers 18
    Table 11: Optimer Pharmaceuticals- Key Clients 18
    Table 12: Optimer Pharmaceuticals- Key Shareholders 19
    Table 13: Optimer Pharmaceuticals- SWOT Analysis Summary 23
    Table 14: Optimer Pharmaceuticals- Value Chain Analysis 28
    Table 15: Optimer Pharmaceuticals- Scorecard 29
    Table 16: Optimer Pharmaceuticals- Key Employees 31
    Table 17: Optimer Pharmaceuticals - Financial and Operational Overview 38